Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,685,376
-$248,776 QoQ
Shares Held
29,983
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#378
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. AZN ranks #2 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
|
5,643 | $240,730 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,685,376 | 29,983 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,934,152 | 30,089 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||